Revenue: The sum of all revenue fields included for a company's operating activities.
Calidi Biotherapeutics, Inc. (CLDI) Revenue data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-23.81M |
|
-- |
|
-- |
|
$21.78M |
|
$-21.78M |
|
$-0.42M |
|
$-22.20M |
|
$-22.20M |
|
$-22.21M |
|
$-22.21M |
|
$-22.21M |
|
$-22.21M |
|
$-21.78M |
|
$-20.20M |
|
8.01M |
|
8.01M |
|
$-2.97 |
|
$-2.97 |
|
| Balance Sheet Financials | |
$10.23M |
|
$0.87M |
|
$3.96M |
|
$14.18M |
|
$9.50M |
|
$0.74M |
|
$2.72M |
|
$12.21M |
|
$1.97M |
|
$1.97M |
|
$1.97M |
|
20.76M |
|
| Cash Flow Statement Financials | |
$-19.69M |
|
$-0.02M |
|
$27.36M |
|
$2.17M |
|
$9.81M |
|
$7.64M |
|
$2.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.08 |
|
-- |
|
-- |
|
0.27 |
|
2.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.71M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-1128.50% |
|
-1128.51% |
|
-156.60% |
|
-818.61% |
|
$0.09 |
|
$-2.46 |
|
$-2.46 |
|